US · QIPT
Quipt Home Medical Corp.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Wilder, KY 41076
- Website
- quipthomemedical.com
Price · as of 2025-09-30
—
Market cap 161.41M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $28.27 | — |
| Intrinsic Value(DCF) | $1,492.91 | — |
| Graham-Dodd Method(GD) | $0.57 | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $2.96 | $336.61 | $92.44 | $0.00 | $0.00 |
| 2012 | $1.06 | $111.21 | $55,150.38 | $0.00 | $0.00 |
| 2013 | $4.56 | $389.11 | $16,566.88 | $0.00 | $0.00 |
| 2014 | $10.42 | $1,120.21 | $298,864.41 | $0.50 | $0.00 |
| 2015 | $8.52 | $34.99 | $1,390,047.33 | $2.90 | $0.00 |
| 2016 | $2.08 | $16.72 | $106.99 | $0.00 | $0.00 |
| 2017 | $5.08 | $20.20 | $3,646.57 | $0.00 | $19.10 |
| 2018 | $1.78 | $186.11 | $6.08 | $3.10 | $0.00 |
| 2019 | $2.98 | $22.11 | $0.26 | $0.00 | $0.00 |
| 2020 | $4.56 | $51.14 | $0.68 | $0.09 | $0.00 |
| 2021 | $5.79 | $28.20 | $0.97 | $0.50 | $0.00 |
| 2022 | $4.43 | $53.73 | $0.35 | $2.19 | $6.04 |
| 2023 | $4.65 | $32.44 | $150.17 | $1.12 | $0.00 |
| 2024 | $2.69 | $28.07 | $236.69 | $0.53 | $0.00 |
| 2025 | $2.43 | $28.27 | $444.38 | $0.57 | $0.00 |
AI valuation
Our deep-learning model estimates Quipt Home Medical Corp.'s (QIPT) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $28.27
- Current price
- —
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1,492.91
— upside
Graham-Dodd
$0.57
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| QIPT | Quipt Home Medical Corp. | $3.63 | 161.41M | +679% | +41,027% | -84% | — | -9.83 | 0.75 | 0.31 | 5.02 | -17.48 | 183.07 | 70.09% | -1.56% | -3.13% | -8.67% | -2.44% | -3.34% | 0.85 | -0.79 | 1.46 | 0.64 | 2.52 | 5625.00% | 3883.00% | 108.00% | 24.09% | 0.50 | 11.61% | 0.00% | 0.00% | 0.12% | -39.68 | 8.33 | 0.62 | 0.40 |
| ANEB | Anebulo Pharmaceuticals, … | $0.36 | 14.68M | — | — | — | — | -9.49 | 6.90 | — | -8.50 | — | 6.90 | 0.00% | — | — | -109.69% | -2464.82% | -104.63% | 0.00 | -24.14 | 53.36 | 52.20 | 1.44 | -2188.00% | — | -2152.00% | -7.89% | -28.32 | -1696.85% | 0.00% | 0.00% | 10.60% | -7.47 | -10.85 | — | 89.17 |
| APYX | Apyx Medical Corporation | $3.27 | 134.17M | +662% | -86% | — | — | -1.69 | 2.80 | 0.83 | -2.79 | -7.60 | 2.80 | 61.04% | -39.18% | -48.78% | -115.17% | -88.10% | -32.70% | 2.73 | -3.19 | 5.26 | 4.40 | -0.42 | 2222.00% | -811.00% | 22461.00% | -47.15% | -1.68 | -87.74% | 0.00% | 0.00% | 0.00% | -2.49 | -2.50 | 0.97 | -0.58 |
| COYA | Coya Therapeutics, Inc. | $4.96 | 82.41M | +515% | -78% | — | +508% | -7.05 | 2.65 | 29.50 | -3.87 | -29.29 | 2.65 | -233.86% | -485.35% | -418.70% | -39.57% | -774.97% | -34.76% | 0.00 | — | 11.59 | 10.22 | 2.23 | 2405.00% | -4079.00% | -804.00% | -9.81% | -2.69 | -484.62% | 0.00% | 0.00% | 5.45% | -3.86 | -6.46 | 18.71 | 11.79 |
| DCGO | DocGo Inc. | $0.72 | 70.23M | +14,095,114% | +69% | — | +90% | 15.52 | 0.97 | 0.50 | 6.11 | 8.75 | 1.25 | 34.64% | 4.65% | 3.24% | 6.43% | 4.79% | 4.23% | 0.18 | 13.24 | 2.50 | 2.46 | -0.70 | 17735.00% | -124.00% | -18676.00% | 20.79% | 0.58 | 22.36% | 417209.23% | 6474653.60% | 417219.88% | 9.70 | 4.31 | 0.45 | 3.36 |
| FONR | FONAR Corporation | $18.60 | 114.82M | +450% | -66% | +79% | -33% | 9.23 | 0.57 | 0.94 | 4.97 | — | 0.60 | 81.67% | 11.12% | 7.99% | 6.30% | 5.87% | 4.95% | 0.23 | 452.88 | 8.45 | 8.14 | -1.07 | -1961.00% | 143.00% | -4388.00% | 7.56% | 0.66 | 4.86% | 0.00% | 0.00% | 4.62% | 6.98 | 10.88 | 0.78 | 2.37 |
| HYPR | Hyperfine, Inc. | $1.07 | 81.53M | +2,340% | -64% | — | — | -1.74 | 1.45 | 5.51 | -0.80 | — | 1.45 | 45.70% | -335.33% | -315.90% | -61.03% | -410.39% | -53.19% | 0.01 | — | 6.15 | 5.26 | 0.89 | -968.00% | 1684.00% | -813.00% | -55.17% | -4.44 | -371.71% | 0.00% | 0.00% | 0.00% | -0.78 | -0.86 | 2.61 | -3.97 |
| NSPR | InspireMD, Inc. | $1.78 | 75.42M | +1,242% | -35% | — | — | -3.72 | 3.30 | 16.99 | -2.61 | — | 3.30 | 21.49% | -478.00% | -456.63% | -84.68% | -1143.45% | -67.77% | 0.06 | — | 5.28 | 4.80 | 0.50 | -732.00% | 1296.00% | 3887.00% | -19.54% | -2.85 | -794.20% | 0.00% | 0.00% | 7.17% | -2.59 | -3.73 | 12.38 | -2.29 |
| RCEL | AVITA Medical, Inc. | $5.03 | 124.96M | +486% | -58% | — | — | -3.02 | -8.82 | 2.05 | -3.30 | — | -6.59 | 82.13% | -58.56% | -67.85% | 799.72% | 463.33% | -71.40% | -0.13 | -8.38 | 0.57 | 0.44 | 0.20 | -2720.00% | 1145.00% | -4647.00% | -21.25% | -0.50 | 344.68% | 0.00% | 0.00% | 27.27% | -3.12 | -4.19 | 1.83 | -10.70 |
| VANI | Vivani Medical, Inc. | $1.23 | 72.67M | — | — | — | — | -2.53 | 3.37 | — | -2.49 | — | 3.37 | 0.00% | — | — | -122.42% | -125.35% | -53.77% | 1.10 | — | 3.41 | 3.11 | -0.04 | -1400.00% | — | -1319.00% | -35.94% | -3.47 | -108.41% | 0.00% | 0.00% | 0.00% | -2.45 | -2.83 | — | -4.16 |
About Quipt Home Medical Corp.
Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
- CEO
- Gregory John Crawford
- Employees
- 1.2K
- Beta
- 0.56
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1,492.91 ÷ —) − 1 = — (DCF, example).